Clinical trial
Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in…
NCT00139256 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00139256 |
|---|---|
| Title | Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section |
| Official title | Randomized Controlled Trial of Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section |
| Lead sponsor | Emory University, Other |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Respiratory Distress Syndrome, Newborn |
| Intervention type | Drug |
| Interventions | Betamethasone |
| Enrollment | 67 |
| Start date | Aug 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Aug 31, 2005 |
| Last update posted | Nov 27, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: